Global In Vitro Diagnostics (IVD) Market

- Opportunity Analysis and Industry Forecast, 2016 - 2025

  • Date December 2016
  • price $3619
 
 

Global In Vitro Diagnostics Market Overview

Global In Vitro Diagnostics Market has the potential to touch around $91.3 billion by 2025, growing at a CAGR of 4.5% during 2017-2025 with the North American region being the largest regional market in the forecast period.

In vitro diagnostics (IVD) is a technique in which medical reagents and devices are used to probe into samples such as urine, blood, stool, tissues and other body fluids, which are derived from the human body to identify, conditions, diseases, and infections. The tests can be performed in stand-alone laboratory, hospital based laboratory and point of care. Microarray techniques, polymerase chain reaction (PCR), mass spectrometry, and sequencing technology that are used for test sample preparation are some of the significant technologies integrated in in vitro diagnostics. Doctors and researchers have been encouraged to shift their focus from traditional diagnostic methods to personalized medicines owing to constant innovations in IVD product design and technology.

The rise in incidences of chronic and infectious diseases along with growing geriatric population prone to immunological disorders has led to the growing need of IVD testing. Moreover, other factors boosting the growth of IVD market include, increase in the application of personalized medicines and boundless knowledge of rare diseases. In addition, the adoption of IVD devices and reagents is on the rise owing to increasing incidences of colorectal cancer, neurological disorders, and gynecological diseases. On the contrary, strict government regulations and hostile reimbursement policies are likely to hinder the growth of the market. The growth potential for IVD market is huge owing to the rising demand for technologically advanced diagnostic devices and increased disposable income of consumers. Furthermore, technological advancements to develop high sensitivity point-of-care (POC) hematology testing is projected to boost the market growth.

In the report, the market is segmented across different categories such as product type, techniques, application, end users and geography .On the basis of product types, the market is segmented into, instruments, reagents, and services & software. The market is segmented according to different techniques into, blood testing, immunodiagnostics, molecular diagnostics, clinical chemistry, tissue diagnostics, and other clinical techniques. Similarly, based on application, the market is further divided into, cancer, infectious diseases, immune system disorders, cardiac diseases, nephrological diseases, gastrointestinal diseases and other indications. On the basis of end-users, the market is categorized into, hospitals, standalone laboratory, academics & medical schools, point of care and others. The geographical breakdown and detailed analysis of each of the aforesaid segments are included for major regions namely, North America, Europe, Asia-Pacific and LAMEA.

To expand their market presence, prominent market players in the IVD market have adopted key strategies, such as product launch, and acquisition. For example, in Oct 2015, Roche Diagnostic launched the new Cobas c513 analyzer, that can be utilized for HbA1c testing for risk identification, diagnosis and stringent monitoring of diabetic patients. Leading market players have opted for acquisition of small diagnostic devices and reagents providers as a part of their strategy to increase their market share. For instance, Pall Corporation was acquired by Danaher Corporation, in August 2015, to enhance the well-established expertise of Danaher Corporation in life science and diagnostic industry. Roche diagnostics, Abbott, Danaher Corporation are few of the key organizations operating in the IVD market. Other companies include, Sysmex Corporation, Johnson and Johnson, bioMrieux, Becton Dickinson, Thermo Fisher Scientific, Inc., Siemens AGand Alere Inc., and Ortho-Clinical Diagnostics. A detailed competitive analysis and profiles of major market players mentioned above are profiled in the report.

KEY BENEFITS FOR STAKEHOLDERS:

  • This report provides an extensive analysis of the current and emerging trends and dynamics in the world IVD market.
  • Geographically, the world IVD market is analyzed based on various regions such as North America, Europe, Asia-Pacific and LAMEA.
  • This report entails the detailed quantitative analysis of the current market and estimations from 2016 to 2025, which assists in identifying the prevailing market opportunities.
  • Exhaustive analysis of the world IVD market by techniques helps in understanding the variants of IVD testing techniques that will gain prominence in the future.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographies.

IVD MARKET KEY SEGMENTS:

By Product type

  • Reagents 
  • Instruments, 
  • Software & Services

By Techniques 

  • Immunodiagnostics 
    • Enzyme-Linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence immunoassay (FIA)    
      • Colorimetric Immunoassay (CI)
    • Rapid Tests
    • Enzyme-Linked ImmunoSpot (ELISPOT)    
    • Radioimmunoassay (RIA)
    • Western blot
  • Blood Testing
  • Molecular Diagnostics
    • Polymerize Chain Reaction (PCR)
    • Isothermal Nucleic Acid Technology (INAAT)
    • Hybridization
    • DNA diagnostics
    • Microarray
    • Others
  • Tissue Diagnostics
  • Clinical Chemistry 
    • Basic metabolic panel
    • Liver panel
    • Lipid profile
    • Thyroid function panel
    • Electrolyte panel
    • Speciality chemicals
  • Other IVD Techniques

By Application 

  • Infectious Diseases
  • Cancer
  • Cardiac Diseases
  • Immune System Disorders
  • Nephrological Diseases 
  • Gastrointestinal Diseases
  • Other Indications

By End Users

  • Standalone Laboratory
  • Hospitals
  • Academic & Medical Schools
  • Point of Care
  • Others 

By Geography

  • North America
    • Canada
    • U.S
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Others
  • Asia-Pacific
    • India
    • China
    • Japan
    • Australia
    • Others
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2027

2.2.1 Base case scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 WORLD IVD MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top impacting factors
3.2.2 Top investment pockets
3.2.3 Top winning strategies

3.3 Porter five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Low threat of new entrants
3.3.4 Threat of substitute
3.3.5 Competitive rivalry

3.4 Government regulations
3.5 Value chain analysis
3.6 Market share analysis, 2014
3.7 Market player positioning, 2015
3.8 Case studies

3.8.1 Case Study 1: Positioning of new IVD Platform by Life Science
3.8.2 Case Study 2: To enhance the operational capabilities of diagnostic chemistry system

3.9 Research & Analysis

3.9.1 Clinical Trials of research studies conducted for IVD market

3.10 Significant Progressions in IVD technologies

3.10.1 Total Laboratory Automation (TLA)
3.10.2 Evolving markets in digital pathology
3.10.3 Omics and Genetics tests in IVD
3.10.4 Point-of-Care testing
3.10.5 Emerging technologies diagnostics and influence on IVD

3.11 Market dynamics

3.11.1 Drivers

3.11.1.1 Increasing incidences of chronic and infectious diseases
3.11.1.2 Technological advancements in IVD
3.11.1.3 Emergence of minimal invasive technologies
3.11.1.4 Increasing government expenditures on healthcare
3.11.1.5 Increase in popularity personalized medicine approach

3.11.2 Restraints

3.11.2.1 Unclear reimbursement policies
3.11.2.2 Stringent Regulatory policies

3.11.3 Opportunities

3.11.3.1 Potential Opportunities for outsourcing
3.11.3.2 Convergence of new Technologies.

Chapter: 4 MARKETBY PRODUCT TYPE, 2015-2022

4.1 Overview

4.1.1 Market size and forecast

4.2 Reagents

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast

4.3 Instruments

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast

4.4 Software and services

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

Chapter: 5 MARKETBY TECHNIQUES, 2015-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 Immunodiagnostics

5.2.1 Key market trends
5.2.2 Key growth factors and opportunities
5.2.3 Market size and forecast
5.2.4 Enzyme-Linked Immunosorbent Assay (ELISA)

5.2.4.1 Market size and forecast
5.2.4.2 Chemiluminescence Immunoassay (CLIA)

5.2.4.2.1 MARKET SIZE AND FORECAST

5.2.4.3 Fluorescence immunoassay (FIA)

5.2.4.3.1 MARKET SIZE AND FORECAST

5.2.4.4 Colorimetric Immunoassay (CI)

5.2.4.4.1 MARKET SIZE AND FORECAST

5.2.5 Rapid Tests

5.2.5.1 Market size and forecast

5.2.6 Enzyme-Linked ImmunoSpot (ELISPOT)

5.2.6.1 Market size and forecast

5.2.7 Radioimmunoassay (RIA)

5.2.7.1 Market size and forecast

5.2.8 Western blot

5.2.8.1 Market size and forecast

5.3 Blood testing

5.3.1 Key market trends
5.3.2 Key growth factors and opportunities
5.3.3 Market size and forecast

5.4 Molecular diagnostics

5.4.1 Key market trends
5.4.2 Key growth factors and opportunities
5.4.3 Market size and forecast
5.4.4 Polymerize Chain Reaction (PCR)

5.4.4.1 Market size and forecast

5.4.5 Isothermal Nucleic Acid Technology (INAAT)

5.4.5.1 Market size and forecast

5.4.6 Hybridization

5.4.6.1 Market size and forecast

5.4.7 DNA diagnostics

5.4.7.1 Market size and forecast

5.4.8 Microarray

5.4.8.1 Market size and forecast

5.4.9 Others

5.4.9.1 Market size and forecast

5.5 Tissue diagnostics

5.5.1 Key market trends
5.5.2 Key growth factors and opportunities
5.5.3 Market size and forecast

5.6 Clinical chemistry

5.6.1 Key market trends
5.6.2 Key growth factors and opportunities
5.6.3 Market size and forecast
5.6.4 Basic metabolic panel

5.6.4.1 Market size and forecast

5.6.5 Liver panel

5.6.5.1 Market size and forecast

5.6.6 Renal profile

5.6.6.1 Market size and forecast

5.6.7 Lipid profile

5.6.7.1 Market size and forecast

5.6.8 Thyroid function panel

5.6.8.1 Market size and forecast

5.6.9 Electrolyte panel

5.6.9.1 Market size and forecast

5.6.10 Speciality chemicals

5.6.10.1 Market size and forecast

5.7 Other IVD techniques

5.7.1 Key market trends
5.7.2 Key growth factors and opportunities
5.7.3 Market size and forecast

Chapter: 6 MARKETBY INDICATION, 2015-2022

6.1 Overview

6.1.1 Market size and forecast

6.2 Infectious diseases

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.3 Cancer

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.4 Cardiac diseases

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.5 Immune system diseases

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.6 Nephrological diseases

6.6.1 Key market trends
6.6.2 Key growth factors and opportunities
6.6.3 Market size and forecast

6.7 Gastrointestinal diseases

6.7.1 Key market trends
6.7.2 Key growth factors and opportunities
6.7.3 Market size and forecast

6.8 Other indications

6.8.1 Key market trends
6.8.2Key growth factors and opportunities
6.8.3Market size and forecast

Chapter: 7 MARKET BY END USERS, 2015-2022

7.1 Overview

7.1.1 Market size and forecast

7.2 Standalone laboratories

7.2.1 Key market trends
7.2.2 Key growth factors and opportunities
7.2.3 Market size and forecast

7.3 Hospitals

7.3.1 Key market trends
7.3.2 Key growth factors and opportunities
7.3.3 Market size and forecast

7.4 Academic and Medical schools

7.4.1 Key market trends
7.4.2 Key growth factors and opportunities
7.4.3 Market size and forecast

7.5 Point of care testing

7.5.1 Key market trends
7.5.2 Growth factors and opportunities
7.5.3 Market size and forecast

7.6 Others

7.6.1 Key market trends
7.6.2 Key growth factors and opportunities
7.6.3 Market size and forecast

Chapter: 8 MARKET BY GEOGRAPHY, 2015-2022

8.1 Overview

8.1.1 Market size and forecast

8.2 North America

8.2.1 Key market trends
8.2.2 Key growth factors and opportunities
8.2.3 Market size and forecast
8.2.4 United states

8.2.4.1 Market size and forecast

8.2.5 Canada

8.2.5.1 Market size and forecast

8.2.6 Mexico

8.2.6.1 Market size and forecast

8.3 Europe

8.3.1 Key market trends
8.3.2 Key growth factors and opportunities
8.3.3 Market size and forecast
8.3.4 Germany

8.3.4.1 Market size and forecast

8.3.5 France

8.3.5.1 Market size and forecast

8.3.6 United Kingdom

8.3.6.1 Market size and forecast

8.3.7 Others

8.3.7.1 Market size and forecast

8.4 Asia Pacific

8.4.1 Key market trends
8.4.2 Key growth factors and opportunities
8.4.3 Market size and forecast
8.4.4 India

8.4.4.1 Market size and forecast

8.4.5 China

8.4.5.1 Market size and forecast

8.4.6 Japan

8.4.6.1 Market size and forecast

8.4.7 Australia

8.4.7.1 Market size and forecast

8.4.8 Others

8.4.8.1 Market size and forecast

8.5 LAMEA

8.5.1 Key market trends
8.5.2 Key growth factors and opportunities
8.5.3 Market size and forecast
8.5.4 Latin America

8.5.4.1 Market size and forecast

8.5.5 Middle East

8.5.5.1 Market size and forecast

8.5.6 Africa

8.5.6.1 Market size and forecast

Chapter: 9 COMPANY PROFILES

9.1 Affymetrix Inc.

9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Financial performance of Affymetrix Inc.
9.1.4 Key Strategies and development
9.1.5 SWOT analysis of Affymetrix

9.2 Alere Inc.

9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Business performance
9.2.4 Key strategies and developments
9.2.5 SWOT analysis of Alere

9.3 Biomerieux

9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Business performance
9.3.4 Key strategies and developments
9.3.5 SWOT analysis of BioMerieux

9.4 Danaher Corporation.

9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Business performance
9.4.4 Key strategies and development
9.4.5 SWOT analysis of Danaher Corporation

9.5 Roche Diagnostics

9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Business performance
9.5.4 Key strategies and developments
9.5.5 SWOT analysis of Roche Diagnostics

9.6 Becton Dickinson and Company

9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Business performance
9.6.4 Key strategies and development
9.6.5 SWOT analysis of Becton Dickinson and Company

9.7 Bio-Rad Laboratories, Inc.

9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Business performance
9.7.4 Key strategies and developments
9.7.5 SWOT analysis of Bio-Rad Laboratories, Inc.

9.8 Abbott Laboratories

9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Business performance
9.8.4 Key strategies and developments
9.8.5 SWOT analysis of Abbott Laboratories

9.9 Bayer AG.

9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Business performance
9.9.4 Key strategies and development
9.9.5 SWOT analysis of Bayer AG

9.10 Arkray, Inc.

9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Key strategies and development
9.10.4 SWOT analysis of Arkray, Inc.

9.11 Sysmex Corporation

9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Business performance
9.11.4 Key strategies and developments
9.11.5 SWOT analysis of Sysmex Corporation

9.12 Johnson & Johnson Pvt Ltd.

9.12.1 Company overview
9.12.2 Company snapshot
9.12.3 Business performance
9.12.4 Key strategies and development
9.12.5 SWOT analysis of Johnson & Johnson Pvt Ltd.

9.13 Siemens AG

9.13.1 Company overview
9.13.2 Company snapshot
9.13.3 Business performance
9.13.4 Key strategies and development
9.13.5 SWOT analysis of Siemens AG

List of Table

TABLE 1 WORLD IVD BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 2 WORLD IVD RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 3 WORLD IVD DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022 2027 ($MILLION)
TABLE 4 PORTERS FIVE FORCES ANALYSIS
TABLE 5 MARKET SHARE AND REVENUE OF CRPC DRUG INNOVATORS
TABLE 6 CLINICAL TRIALS - IN VITRO DIAGNOSTIC DEVICES
TABLE 7 GLOBAL INCIDENCES OF DISEASES
TABLE 8 MARKETBY PRODUCT TYPE, 2015-2022 ($MILLION)
TABLE 9 MARKETBY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 10 WORLD IVD REAGENTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 11 WORLD IVD INSTRUMENTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 12 WORLD IVD SOFTWARE AND SERVICES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 13 MARKET BY TECHNIQUE, 2015-2022 ($MILLION)
TABLE 14 WORLD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 15 WORLD IMMUNODIAGNOSTIC TECHNIQUE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 16 WORLD ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) MARKET, 2015-2022 ($MILLION)
TABLE 17 WORLD BLOOD TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 18 WORLD MOLECULAR DIAGNOSTICS MARKET, BY TECHNIQUE, 2015-2022 ($MILLION)
TABLE 19 WORLD MOLECULAR DIAGNOSTICS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 20 WORLD TISSUE DIAGNOSTICS TECHNIQUE MARKET, 2015-2022, ($MILLION)
TABLE 21 WORLD CLINICAL CHEMISTRY TECHNIQUE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 22 WORLD OTHER CLINICAL TECHNIQUES MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 23 WORLD IVD MARKET, BY INDICATION, 2015-2022 ($MILLION)
TABLE 24 WORLD IVD INFECTIOUS DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 25 WORLD IVD CANCER MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 26 WORLD IVD CARDIAC DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 27 WORLD IVD IMMUNE SYSTEM DISORDER MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 28 WORLD IVD NEPHROLOGICAL DISEASES MARKET, BY GEOGRAPHY, 2015-2022, ($MILLION)
TABLE 29 WORLD IVD GASTRINTESTINAL DISEASES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 30 WORLD IVD OTHER INDICATION MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 31 MARKETBY END USER, 2015-2022, ($MILLION)
TABLE 32 WORLD IVD STANDALONE LABORATORIES MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 33 WORLD IVD HOSPITALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 34 WORLD IVD ACADEMIC AND MEDICAL SCHOOLS MARKET, BY GEOGRAPHY, 2015- 2022 ($MILLION)
TABLE 35 WORLD IVD POINT OF CARE TESTING MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 36 WORLD IVD OTHERS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 37 WORLD IVD MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
TABLE 38 NORTH AMERICA IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 39 UNITED STATES IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 40 CANADA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 41 MEXICO IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 42 EUROPE IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 43 GERMANY IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 44 FRANCE IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 45 UNITED KINGDOM IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 46 OTHERS EUROPEAN IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 47 ASIA PACIFIC IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 48 INDIA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 49 CHINA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 50 JAPAN IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 51 CATEGORIZATION OF IVD DEVICES
TABLE 52 AUSTRALIA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 53 OTHERS IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 54 LAMEA IVD MARKET, BY TECHNIQUES, 2015-2022 ($MILLION)
TABLE 55 LATIN AMERICA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 56 MIDDLE EAST IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 57 AFRICA IVD MARKET REVENUE, BY TECHNIQUES, 2015-2022, ($MILLION)
TABLE 58 COMPANY SNAPSHOT OF AFFYMETRIX INC.
TABLE 59 ALERE INC. COMPANY SNAPSHOT
TABLE 60 BIOMERIEUX COMPANY SNAPSHOT
TABLE 61 DANAHER CORPORATION COMPANY SNAPSHOT
TABLE 62 ROCHE DIAGNOSTICS COMPANY SNAPSHOT
TABLE 63 BECTON DICKINSON AND COMPANY SNAPSHOT
TABLE 64 BIO-RAD LABORATORIES, INC. COMAPNY SNAPSHOT
TABLE 65 ABBOTT LABORATORIES SNAPSHOT
TABLE 66 BAYER AG COMPANY SNAPSHOT
TABLE 67 ARKRAY, INC. COMPANY SNAPSHOT
TABLE 68 SYSMEX CORPORATION COMPANY SNAPSHOT
TABLE 69 JOHNSON & JOHNSON PVT LTD. COMPANY SNAPSHOT
TABLE 70 SIEMENS AGCOMPANY SNAPSHOT

List of Figures

FIG. 1 WORLD IVD MARKET SNAPSHOT
FIG. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022-2027)
FIG. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022-2027)
FIG. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022-2027)
FIG. 4 TOP IMPACTING FACTORS
FIG. 5 TOP INVESTMENT POCKETS OF IVD MARKET BY TECHNIQUES 2015-2022.
FIG. 6 TOP WINNING STRATEGIES
FIG. 7 TOP WINNING STRATEGIES
FIG. 8 VALUE CHAIN ANALYSIS FOR IVD MARKET
FIG. 9 MARKET SHARE OF KEY PLAYERS IN IVD MARKET
FIG. 10 MARKET PLAYER POSITIONING, 2014
FIG. 11 WORLD CHEMILUMINESCENCE IMMUNOASSAY (CLISA) MARKET, 2015-2022 ($MILLION)
FIG. 12 WORLD FLUORESCENCE IMMUNOASSAY (FIA) MARKET, 2015-2022 ($MILLION)
FIG. 13 WORLD COLORIMETRIC IMMUNOASSAY (CI) MARKET, 2015-2022 ($MILLION)
FIG. 14 WORLD RAPID TESTS MARKET, 2015-2022 ($MILLION)
FIG. 15 WORLD ENZYME-LINKED IMMUNOSPOT (ELISPOT) MARKET, 2015-2022 ($MILLION)
FIG. 16 WORLD RADIOIMMUNOASSAY (RIA) MARKET, 2015-2022 ($MILLION)
FIG. 17 WORLD WESTERN BLOT TECHNIQUE MARKET, 2015-2022 ($MILLION)
FIG. 18 WORLD POLYMERIZE CHAIN REACTION PCR MARKET, 2015-2022 ($MILLION)
FIG. 19 WORLD ISOTHERMAL NUCLEIC ACID TECHNOLOGY (INAAT) MARKET, 2015-2022 ($MILLION)
FIG. 20 WORLD HYBRIDIZATION MARKET, 2015-2022 ($MILLION)
FIG. 21 WORLD DNA DIAGNOSTICS MARKET, 2015-2022 ($MILLION)
FIG. 22 WORLD MICROARRAY MARKET, 2015-2022 ($MILLION)
FIG. 23 WORLD OTHER MOLECULAR DIAGNOSTIC MARKET, 2015-2022 ($MILLION)
FIG. 24 WORLD BASIC METABOLIC PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 25 WORLD LIVER PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 26 WORLD RENAL PROFILE MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 27 WORLD LIPID PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 28 WORLD THYROID FUNCTION PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 29 WORLD ELECTROLYTE PANEL MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 30 WORLD SPECIALITY CHEMICALS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)
FIG. 31 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE, 2012-2014, $MILLION
FIG. 32 KEY FINANCIALS OF AFFYMETRIX INC. REVENUE BY SEGMENTS
FIG. 33 KEY FINANCIALS OF AFFYMETRIX INC.CORPORATION REVENUE BY GEOGRAPHY
FIG. 34 SWOT ANALYSIS OF AFFYMETRIX INC.
FIG. 35 KEY FINANCIALS OF ALERE INC. REVENUE, 2012-2014, $MILLION
FIG. 36 ALERE INC., % NET SALES BY BUSINESS SEGMENTS, 2014
FIG. 37 ALERE INC., % NET SALES BY GEOGRAPHY, 2014
FIG. 38 SWOT ANALYSIS OF ALERE INC.
FIG. 39 KEY FINANCIALS OF BIOMERIEUX REVENUE, 2011-2014, $MILLION
FIG. 40 BIOMERIEUX, % NET SALES BY TECHNOLOGY, 2014
FIG. 41 BIOMERIEUX, % NET SALES BY GEOGRAPHY, 2014
FIG. 42 SWOT ANALYSIS OF BIOMERIEUX
FIG. 43 DANAHER CORPORATION, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 44 DANAHER CORPORATION, % NET SALES BY GEOGRAPHY, 2014
FIG. 45 SWOT ANALYSIS OF DANAHER CORPORATION
FIG. 46 KEY FINANCIALS OF ROCHE DIAGNOSTICS REVENUE, 2012-2014, $MILLION
FIG. 47 ROCHE DIAGNOSTICS, % NET SALES BY BUSINESS SEGMENT, 2014
FIG. 48 ROCHE DIAGNOSTICS, % NET SALES BY GEOGRAPHY, 2014
FIG. 49 SWOT ANALYSIS OF ROCHE DIAGNOSTICS
FIG. 50 KEY FINANCIALS OF BECTON, DICKINSON AND COMPANY REVENUE, 2011-2014, $MILLION
FIG. 51 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY REVENUES BY SEGMENT 2014
FIG. 52 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY SALES BY GEOGRAPHY 2014
FIG. 53 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY
FIG. 54 KEY FINANCIALS OF BIO-RAD LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 55 BIO RAD LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 56 BIO RAD LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 57 SWOT ANALYSIS OF BIO-RAD LABORATORIES, INC.
FIG. 58 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 59 ABBOTT LABORATORIES, INC., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 60 ABBOTT LABORATORIES, INC., % REVENUE BY GEOGRAPHY, 2014
FIG. 61 SWOT ANALYSIS OF ABBOTT LABORATORIES
FIG. 62 KEY FINANCIALS OF ABBOTT LABORATORIES REVENUE, 2012-2014, $MILLION
FIG. 63 BAYER AG, % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 64 SWOT ANALYSIS OF BAYER AG
FIG. 65 SWOT ANALYSIS OF ARKRAY, INC.
FIG. 66 KEY FINANCIALS OF SYSMEX CORPORATION REVENUE, 2012-2014, $MILLION
FIG. 67 SYSMEX CORPORATION, % REVENUE, BY BUSINESS SEGMENT, 2014
FIG. 68 SYSMEX CORPORATION, % REVENUE, BY PRODUCT TYPE, 2014
FIG. 69 SYSMEX CORPORATION, % REVENUE BY GEOGRAPHY, (2014)
FIG. 70 SWOT ANALYSIS OF SYSMEX CORPORATION
FIG. 71 KEY FINANCIALS OF JOHNSON & JOHSNON $MILLION (2012-2014)
FIG. 72 FINANCIAL REVENUES BY SEGMENTS (2014)
FIG. 73 FINANCIAL REVENUES BY GEOGRAPHY (2014)
FIG. 74 SWOT ANALYSIS OF JOHNSON & JOHNSON PVT LTD.
FIG. 75 SIEMENS AG., % REVENUE BY BUSINESS SEGMENT, 2014
FIG. 76 SIEMENS AG., % REVENUE BY GEOGRAPHY, 2014
FIG. 77 SWOT ANALYSIS OF SIEMENS AG

 

 

 

 

License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Are You?

  • Startup
  • Student or University
  • Research Scholar
  • Government Agencies
  • Non-profit Organization
  • NGO / Self Help Group
  • First Time Buyer

Get Discount     btn-arrow

Please Select Format

Need More Information

Why Progressive Markets

The market research services provided by Progressive Market Research (PMR) are restricted to publications, which may also include insignificant market data. The services are for the internal use of customers only and they do not have any rights to utilize this data for general publications or/and disclosure to third parties. As data is gathered through research activities such as online surveys and interviews of industry experts, it may have variations and fluctuation due to constantly changing market conditions. Thus, Progressive Market Research holds no responsibility of misleading or false information gathered from these sources.

Progressive Market Research understands and resp

Recently Viewed Reports

Similar Market Research Report

blog
Jun
2017
Global Baby Drinks Market

Baby drinks includes infant formulas and vegetables & fruit juices suitable for consumption by children up to three years of age. Infant formulas consist of vitamins & minerals, carbohydrates, proteins, ... Read More >>

 

Get Email Alert